- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Alkem Laboratories Limited has informed the Exchange about Intimation under Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 ( SEBI LODR Regulations ) - Outcome of the 52nd Annual General Meeting of the Company and Disclosure of voting results thereat.
Alkem Labs reported Q1 FY27 revenue of INR 3,740 Cr (+11% YoY), with India sales up 10.3% and International up 16%. EBITDA margin was 20.5%, while net profit degrew 21.7% due to taxation. The company outperformed the Indian pharma market by 100 bps. Management expects ~12% India growth for FY27,...